Situation Awareness: Cautious. Wednesday’s tape was a broadening rally masked by modest headline gains — the S&P 500 closed +0.21% at 7707.98, the Nasdaq +0.16% at 26352.12, and the Dow +0.22% at 53463.05, but the S&P 500 Equal Weighted Index jumped +1.0% as rate-sensitive groups, health care and materials led while semiconductors sank again (PHLX Semi -2.1%). The defining catalysts: Moderna’s (MRNA) +177% cancer-vaccine moonshot and the Treasury’s decision to at least double long-dated buyback operations, easing the 10-yr to 4.65%. Trade mode for tomorrow: selective and constructive — lean into the rotation winners (health care, materials, homebuilders) but respect ongoing chip weakness. Regime context — 54.0% of stocks closed above their 40-day SMA (vs 56.3% prior day, regime held at Cautious), and the 4% Bull/Bear gauge shows 403 bulls vs. 134 bears. The 5-day trend is choppy — Tuesday’s momentum-driven washout was followed by Wednesday’s broad-based bounce, signaling a rotation rather than a directional trend.
SIP: MRNA MRK TEM COIN
- What’s working: 2LYNCH continuation fired 39 signals (MELI, FICO, TEM, ALNY), D9M posted 20 (NOW, UBER, ACN, CSGP), Reversal Bullish just 7 (ORCL, ASTS) — breakout breadth outweighs reversals, favoring trend-follow into leaders.
- Leading sectors: Healthcare +1.11%, Consumer Defensive +0.75%, Basic Materials +0.71%; leading themes: Crypto/Blockchain +6.37%, Research +3.24%, Gold/Silver Mining +3.09%.
- Key event: Moderna (MRNA) +176.97% and Merck (MRK) +12.61% on positive experimental cancer-vaccine data lit up the entire biotech complex (iShares Biotech ETF +6.6%).
- Regime threading: morning SA called Cautious (56.3%), closing is Cautious (54.0%) — held, as breadth softened intraday but the equal-weight rally kept participation broad.
- DEP watchlist: NOW $127.19, UBER $78.04, CSGP $33.74, ACN $183.35, CMG $34.66 — all D9M setups with institutional backing.
- SIPS: MELI $1909.18, FICO $1161.38, ALNY $242.65 — continuation swing candidates from the 2LYNCH scan.
Market Scorecard
- SPY, QQQ, and IWM technical levels are data unavailable today. Using index proxies: S&P 500 +0.21% (7707.98), Nasdaq +0.16% (26352.12), Dow +0.22% (53463.05); the S&P 500 Equal Weight (+1.0%) told the real story of broadening.
- Breadth final: 54.0% above 40-day SMA (down 2.3pp) and just 41% above 20-day SMA (down 14.0pp) — a notable near-term deterioration despite the up day, a rotation fingerprint.
- Volume context: NYSE 1.19 bln shares with advancers leading 1755-996; Nasdaq 2878-2079 advancers. Broad participation supports mild accumulation in the non-tech complex, distribution in semis.
Today’s Scorecard — What Worked & What Didn’t
- Winners: Health care (+3.5% sector) on MRNA +176.97%, MRK +12.61%; TEM +23.9%, ILMN +8.9%, TWST +22.7%, ALNY +6.1% rode the biotech surge.
- Second theme: Rate-sensitive rotation — homebuilders (iShares Home Construction ETF +3.1%) and consumer discretionary (+2.1%) with TGT +4.30%, LOW +2.35%, AMZN +2.46%, TSLA +4.23%; materials (+1.7%) with NEM +7.85% on precious metals.
- What failed: Semiconductors extended the rout — PHLX Semi -2.1%, Semiconductor Equipment theme -6.12% (AEHR -13.16%, ASYS -12.15%), dragging IT (-0.7%) and industrials (-0.9%). TJX slipped -3.34% despite a Q2 beat on soft Marmaxx comps.
- Breadth trend: 4% Bull/Bear flipped decisively bullish (403 vs 134, from 144 vs 319 yesterday), but the drop in stocks above the 20-day SMA warns the bounce is uneven.
Key Earnings & Economic Calendar
- Most impactful: Target (TGT 159.03, +4.30%) and Lowe’s (LOW 220.71, +2.35%) rallied on earnings; TJX (145.81, -3.34%) fell despite an EPS beat as Marmaxx comps rose just +1%.
- Notable chip-adjacent: Analog Devices (ADI +1%) posted a record first-ever $4 bln quarter (+39.2% yr/yr) and guided Q4 above consensus on AI/data-center demand — a bright spot in an ugly semi tape.
- Economic data: Today’s FOMC July minutes showed many participants see a rate hike likely if inflation doesn’t ease; 20-yr auction tailed to soft demand (5.204% high yield). Watch the standard weekly jobless claims cadence tomorrow.
- Tomorrow’s earnings: retail/consumer reports continue to flow — monitor after-hours reactions in the discretionary complex given today’s TGT/LOW strength.
Tomorrow’s Watchlist & Setups
- MRNA at $174.65 — parabolic Darvas breakout on 26x RVOL; too extended to chase, watch for a first-pullback base rather than the open.
- NOW at $127.19 — D9M setup at demand (121.66-125.72), +6.45% on 1.47 RVOL; trigger over intraday high with supply near 135.
- MELI at $1909.18 — 2LYNCH continuation, +7.3%; buyable on tight consolidation above prior highs.
- PAAS at $50.33 — gold/silver momentum (+8%, gap +5.87%), riding the metals theme; entry on hold above demand with supply at 53-54.
- Sector focus: Health care/biotech — the MRNA catalyst has re-rated the whole group (XBI approaching its 2021 record 174.79); look for sympathy continuation names, not the parabola itself.
Strategy Outlook & Scenarios
- Bullish scenario: If breadth reclaims above the 20-day (back over ~55%) and semis stabilize, the equal-weight leadership broadens into a durable rotation — add to health care, materials, homebuilders.
- Bearish scenario: Another PHLX Semi leg down that finally drags mega-cap tech would crack the headline indices; a slide in pct_above_sma40 below 50% flips the regime toward Cautious Bearish.
- Signal counts: 2LYNCH 39, D9M 20, Reversal 7 — continuation setups dominate versus reversals, a constructive (trend-follow) tilt versus the prior day’s washout.
- Regime forecast: Cautious. Breadth held near 54% with a bullish 4% flip, but the sharp 20-day breadth drop keeps conviction in check.
Action Codes
- CRT (Controlled Risk Taking): Rotation offers real leadership (health care +3.5%, materials +1.7%) but semi weakness demands sized-down, selective entries.
- T3A (Think 3 Days Ahead): The Treasury buyback change (effective Sept 9) and FOMC minutes set a multi-day rate narrative — position for the rotation to persist, not just today’s pop.
Summary & Final Thoughts
- Game plan: Buy strength in the rotation winners — biotech/health care, homebuilders, precious-metals miners — while avoiding falling knives in semiconductors and equipment.
- Key risk: The chip decline (PHLX Semi -2.1%, -5.0% Tuesday) is not done; a break in mega-cap tech could overwhelm the broadening beneath the surface.
- Overall stance: Selective. The tape rewards stock-picking in the rotation, not index-level aggression — respect the 41% above-20-day breadth warning.